Tag: Pop
News alerts
Latest content
- Tozorakimab shows significant benefit in two major COPD trials

- Daratumumab becomes first oncology injectable approved for patient administration

- Laigo Bio completes final close of €17m seed financing round

- Axplora announces expansion as newest part of $60m API investment programme

- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
